Recent content by Biomonster

Stock hit new 52W high yesterday ..... A LOT of BIG milestones are around the corner which likely will push the stock toward 200p and higher . The most important milestones are the FDA Decision for Alkindi in September and the EMA Decision for Chronocort in early Q1 . STRONG BUY stock likely to...

DNL =BIG Drug with potential FDA approval in 2 months = 5+ BAGGER GEM Diurnal Group (DNL) = MCap £38 M / Cash £15 M or enough untill early 2022 / LOTS of BIG milestones on the way = Still the MOST attractive and CHEAPEST pharma stock in UK has potential to run toward 200p very fast especially...

GREAT News out today ..NDA accepted by FDA and the Drug could be approved in Q3 .. Still the CHEAPEST and most attractive small cap Biotech in UK . A potential 10 Bagger here Diurnal : US FDA Accepts NDA Application for Alkindi...

The most underpriced and attractive british biotech company with MASSIVE upside potential .Still think this sleeping giant has 10+ bagger upside potential and 2020 could be the year for DNL with all the approvals and partnerships expected during the year .GL Diurnal (DNL) Market Cap £24 M...

GREAT NEWS OUT Market cap £25 million Chronocort MAA Submitted in Europe https://www.investegate.co.uk/diurnal-group-plc--dnl-/rns/chronocort-maa-submitted-in-europe/201912160700079030W/ Significant opportunity to address unmet patient need, in a market estimated at $250 million Marketing...

Great news out today and much more to come ... Diurnal (DNL) Price: 30 p --Market Cap £26 M --Cash £9 M--MEGA milestones expected within 4 weeks = 300-500% GEM Approaching anumber of near-term milestones....5 November 2019...

the good news is there are no sellers here but looks like we have to wait until news hit the wire .DNL still the most attractive and underpriced pharma stock in UK , searching the entire uk healthcare sector and doesnt find a better one than DNL .

back up she goes looks like consolidation is over , with goods news this underpriced low float stock will hit 100p quickly and many big milestones expected during 2H 2019 .GL

the selloff on the stock markets created a great buying opportunity on this still undiscovered goldmine .GL -------- Send an email to the company askting if they are still on track for NDA and MAA submission of their drugs and about potential partnerships . Below is the response Dear Mr...

love this undiscovered stock its almost everyday in the green ..Market cap still at laughable 40 million makes this one the most attractive and underpriced UK pharma stock and it could hit 100p+ in no time on those news below upfront payments from potential US-Partnership alone could be higher...

Shareholders here should put a high gtc sell order in like 100p ,so your shares will not available for shorts and more important it reduces the free shares on market so it helps the stock to make even much bigger jumps on good news . Thank you guys How to Prevent your Shares Holdings from...

up she goes again now trading at 46.2p or 8.7%+ , and DNL is still heavily underpriced at 39 million valuation .The Big News still to come which could push this undiscovered stock even faster to the upside . Upcoming Milestones Alkindi launch in additional EU States during 2H 2019 US-NDA...

Big US-Partnership news which means upfront payments to DNL could hit the wire anytime now such news could push this low float stock 50-100% because of its very low valuation (£35.5 Million) .GL "Diurnal has received strong interest in Alkindi® and Chronocort® for the US and will continue to...

Share Talk Bulletin Board Heroes, Thursday 25th July 2019 https://www.share-talk.com/share-talk-bulletin-board-heroes-thursday-18th-july-2019-2/

42p+ and moving higher could hit 50p this or early next week .GLTA